PBH Q3 2026 Earnings Call Summary

1. Key Financial Results and Metrics

Revenue: $283 million, slightly above forecast but down 2.4% year-over-year (2.2% decline excluding FX).
Adjusted EPS: $1.14, down from $1.22 in the prior year.
Gross Margin: 55.5%, consistent with expectations.
Free Cash Flow: $209 million year-to-date, up 13% from the previous year, with a full-year outlook of $245 million or more.
Net Debt: Approximately $1 billion, with a leverage ratio of 2.6 times.

2. Strategic Updates and Business Highlights

Supply Chain Improvements: Sequential improvement in Clear Eyes supply for the second consecutive quarter, aided by new suppliers and the acquisition of Pillar Five, which will enhance production capabilities.
Diversified Customer Base: Strong order trends in growing channels (e.g., e-commerce) helped offset declines in other areas affected by macroeconomic challenges.
Capital Allocation: $46 million in stock repurchases and the acquisition of Pillar Five for over $110 million, reflecting a disciplined capital allocation strategy.

3. Forward Guidance and Outlook

Sales Outlook: Narrowed guidance to approximately $1.1 billion for fiscal 2026, reflecting ongoing consumption momentum in growth channels but tempered by slower order patterns in others.
EPS Guidance: Adjusted diluted EPS expected to be around $4.54 for the year.
Continued Free Cash Flow Growth: Anticipated to maintain strong cash flow generation, with expectations for sequential improvement in Clear Eyes supply into Q4.

4. Bad News, Challenges, or Points of Concern

Revenue Decline: Year-to-date revenue decreased 3.9% organically, primarily due to supply constraints in the eye care category and softness in analgesics and cough/cold categories.
Consumer Volatility: Ongoing shifts in consumer shopping habits and inventory destocking affecting certain distribution channels.
Write-off of Supplier Loan: Approximately $10 million write-off related to a supplier loan, reflecting risks in maintaining supply continuity.

5. Notable Q&A Insights

Consumer Behavior: Management noted a shift in consumer purchasing patterns, with some channels experiencing destocking while others, particularly e-commerce, continue to grow.
Eye Care Supply Recovery: Management expects gradual restocking and improved supply levels for Clear Eyes, with a focus on marketing efforts to support demand growth.
Advertising and Marketing Strategy: Future marketing investments will be aligned with evolving consumer shopping behaviors, particularly as e-commerce grows.
M&A Focus: Future acquisitions will primarily target brands that enhance long-term value rather than facilities or vertical integration.

Overall, PBH demonstrated resilience in navigating a challenging consumer environment while maintaining a strong financial profile and strategic focus on growth opportunities. However, ongoing supply chain issues and shifting consumer behaviors present notable challenges.

PBH — Prestige Consumer Healthcare Inc.